SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Costs and Cost-Effectiveness of Unrelated Donor Bone Marrow Transplantation for Chronic Phase Chronic Myelogenous Leukemia
7 references·1 citing·31 second hop
The Costs and Cost-Effectiveness of Unrelated Donor Bone Marrow Transplantation for Chronic Phase Chronic Myelogenous Leukemia (1998)The Costs and Cost-Effectiveness of Unrel…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness (1995)Five‐Hundred Life‐Saving Inte…Markov Models in Medical Decision Making (1993)Markov Models in Medical Deci…Efficacy and Cost-Effectiveness of Cancer Treatment: Rational Allocation of Resources Based on Decision Analysis (1993)Efficacy and Cost-Effectivene…How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)How attractive does a new tec…Cost-effectiveness Analysis of End-stage Renal Disease Treatments (1987)Cost-effectiveness Analysis o…Utilization and Costs of Medicare Services by Beneficiaries in Their Last Year of Life (1984)Utilization and Costs of Medi…Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma (2009)Cost Effectiveness of Rituxim…Alternative to Mental Hospital Treatment (1980)A methodological framework for assessing health indices (1985)Measurement of health state utilities for economic appraisal (1986)The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument (1993)A study of the quality of life and cost-utility of renal transplantation (1996)A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial (2012)A comparative economic analysis of pegylated liposomal doxorubicin versus topotecan in ovarian cancer in the USA and the UK (2002)Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis (2004)Discounting Health Effects in Pharmacoeconomic Evaluations (2005)Where Now for Saving Lives? (1976)Value of a Life: What Difference Does It Make?1 (1981)Trust, Emotion, Sex, Politics, and Science: Surveying the Risk‐Assessment Battlefield (1999)The RAND-36 measure of health-related quality of life (2001)The Value of a Statistical Life: A Critical Review of Market Estimates Throughout the World (2003)Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Cost-Benefit Analysis: A Handbook (1978)Equity versus efficiency: a dilemma for the NHS (2001)XXIV. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. In a letter to Francis Baily, Esq. F. R. S. &c (1825)The Markov Process in Medical Prognosis (1983)An Introduction to Markov Modelling for Economic Evaluation (1998)Handling Uncertainty in Cost-Effectiveness Models (2000)Review of guidelines for good practice in decision-analytic modelling in health technology assessment (2004)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer (1995)Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer. (1998)The effectiveness of cost-effectiveness analysis in containing costs (1998)Cost-Effectiveness Analysis of Transplantation (1986)The Fourth Stage of the Epidemiologic Transition: The Age of Delayed Degenerative Diseases (1986)The High Costs of Death: Should Health Plans Get Higher Payments When Members Die? (1998)
this work references cited by second hop

References

  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 1993Markov Models in Medical Decision Making2,446 cited
  • 1992How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.1,581 cited
  • 1995Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness1,318 cited
  • 1993Efficacy and Cost-Effectiveness of Cancer Treatment: Rational Allocation of Resources Based on Decision Analysis162 cited
  • 1984Utilization and Costs of Medicare Services by Beneficiaries in Their Last Year of Life103 cited
  • 1987Cost-effectiveness Analysis of End-stage Renal Disease Treatments89 cited

Cited by

  • 2009Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma49 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work